141 related articles for article (PubMed ID: 18219197)
1. Gene expression profiling of peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome by cDNA microarrays.
Komatsuda A; Wakui H; Iwamoto K; Harada M; Okumoto Y; Sawada K
Am J Nephrol; 2008; 28(4):539-47. PubMed ID: 18219197
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome.
Okuyama S; Komatsuda A; Wakui H; Aiba N; Fujishima N; Iwamoto K; Ohtani H; Sawada K
Nephrol Dial Transplant; 2005 Mar; 20(3):539-44. PubMed ID: 15671071
[TBL] [Abstract][Full Text] [Related]
3. GATA-3 is upregulated in peripheral blood mononuclear cells from patients with minimal change nephrotic syndrome.
Komatsuda A; Wakui H; Iwamoto K; Togashi M; Masai R; Maki N; Sawada K
Clin Nephrol; 2009 Jun; 71(6):608-16. PubMed ID: 19473628
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of histone H3 lysine 4 trimethylation in peripheral blood mononuclear cells of minimal change nephrotic syndrome patients.
Zhang L; Dai Y; Peng W; Lu J; Zhang Y; Wang L
Am J Nephrol; 2009; 30(6):505-13. PubMed ID: 19797895
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood.
González E; Neuhaus T; Kemper MJ; Girardin E
Nephrol Dial Transplant; 2009 Jan; 24(1):149-55. PubMed ID: 18697798
[TBL] [Abstract][Full Text] [Related]
6. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
Ozaki T
Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
[TBL] [Abstract][Full Text] [Related]
7. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
[TBL] [Abstract][Full Text] [Related]
8. Circulating plasmablasts and high level of BAFF are hallmarks of minimal change nephrotic syndrome in adults.
Oniszczuk J; Beldi-Ferchiou A; Audureau E; Azzaoui I; Molinier-Frenkel V; Frontera V; Karras A; Moktefi A; Pillebout E; Zaidan M; El Karoui K; Delfau-Larue MH; Hénique C; Ollero M; Sahali D; Mahévas M; Audard V
Nephrol Dial Transplant; 2021 Mar; 36(4):609-617. PubMed ID: 33241414
[TBL] [Abstract][Full Text] [Related]
9. [DNA typing of HLA-class II genes in idiopathic nephropathy].
Ogahara S; Michinaga I; Hiratsuka T; Abe K; Naito S
Nihon Rinsho; 1992 Dec; 50(12):3072-8. PubMed ID: 1283419
[TBL] [Abstract][Full Text] [Related]
10. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome.
Lin CY; Chien JW
Acta Paediatr Taiwan; 2004; 45(2):77-80. PubMed ID: 15335115
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of interleukin-4--related genes in Japanese children with minimal change nephrotic syndrome.
Kobayashi Y; Arakawa H; Suzuki M; Takizawa T; Tokuyama K; Morikawa A
Am J Kidney Dis; 2003 Aug; 42(2):271-6. PubMed ID: 12900808
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes.
Audard V; Zhang SY; Copie-Bergman C; Rucker-Martin C; Ory V; Candelier M; Baia M; Lang P; Pawlak A; Sahali D
Blood; 2010 May; 115(18):3756-62. PubMed ID: 20200355
[TBL] [Abstract][Full Text] [Related]
13. Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy.
Mao J; Zhang Y; Du L; Dai Y; Yang C; Liang L
Pediatr Nephrol; 2006 Nov; 21(11):1666-75. PubMed ID: 16941146
[TBL] [Abstract][Full Text] [Related]
14. Urotensin 2 and retinoic acid receptor alpha (RARA) gene expression in IgA nephropathy.
Woo KT; Lau YK; Zhao Y; Puong KY; Tan HB; Fook-Chong S; Wong KS; Chan CM
Ann Acad Med Singap; 2010 Sep; 39(9):705-9. PubMed ID: 20957306
[TBL] [Abstract][Full Text] [Related]
15. Studies of a glomerular permeability factor in patients with minimal-change nephrotic syndrome.
Yoshizawa N; Kusumi Y; Matsumoto K; Oshima S; Takeuchi A; Kawamura O; Kubota T; Kondo S; Niwa H
Nephron; 1989; 51(3):370-6. PubMed ID: 2918948
[TBL] [Abstract][Full Text] [Related]
16. Comparison of lipid and fatty acid metabolism between minimal change nephrotic syndrome and membranous nephropathy.
Fujita T; Nakamura N; Kumasaka R; Shimada M; Murakami R; Osawa H; Yamabe H; Okumura K
In Vivo; 2006; 20(6B):891-3. PubMed ID: 17203785
[TBL] [Abstract][Full Text] [Related]
17. Minimal change nephrotic syndrome and prohibitin-2 gene polymorphism.
Sugimoto K; Miyazawa T; Miyazaki K; Yanagida H; Enya T; Nishi H; Wada N; Okada M; Takemura T
Clin Exp Nephrol; 2017 Aug; 21(4):665-670. PubMed ID: 27812762
[TBL] [Abstract][Full Text] [Related]
18. [The effect of peripheral blood mononuclear cell products from children with nephrotic syndrome on thromboxane A2 metabolism].
Watanabe Y; Suzui J; Ichikawa Y; Yoshida K; Suzuki H
Arerugi; 1995 May; 44(5):547-55. PubMed ID: 7619008
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome.
Cho BS; Yoon SR; Jang JY; Pyun KH; Lee CE
Pediatr Nephrol; 1999 Apr; 13(3):199-204. PubMed ID: 10353405
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.
Matsumoto K; Kanmatsuse K
Clin Nephrol; 1999 Jul; 52(1):10-8. PubMed ID: 10442490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
